臺灣醫療影像與病理報告FHIR研究實作指引
0.1.0 - DSTU0 ci-build

臺灣醫療影像與病理報告FHIR研究實作指引 - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Capability Statement
... 3 Downloads
... 4 Example Image
... 5 Example NASH
... 6 Example NSCLC
... 7 Image Profiles
... 8 Models
... 9 NASH Profiles
... 10 NSCLC Profiles
... 11 Searchparameters
... 12 Security
... 13 Terminologies
... 14 Visual Image
... 15 Visual NASH
... 16 Visual NSCLC
... 17 Artifacts Summary
.... 17.1 Image CapabilityStatement
.... 17.2 NASH CapabilityStatement
.... 17.3 NSCLC CapabilityStatement
.... 17.4 DiagnosticReport-category
.... 17.5 DiagnosticReport-code
.... 17.6 DiagnosticReport-date
.... 17.7 DiagnosticReport-id
.... 17.8 DiagnosticReport-status
.... 17.9 DiagnosticReport-subject
.... 17.10 ImagingStudy-dicom-class
.... 17.11 ImagingStudy-endpoint
.... 17.12 ImagingStudy-id
.... 17.13 ImagingStudy-identifier
.... 17.14 ImagingStudy-instance
.... 17.15 ImagingStudy-modality
.... 17.16 ImagingStudy-patient
.... 17.17 ImagingStudy-series
.... 17.18 ImagingStudy-started
.... 17.19 ImagingStudy-status
.... 17.20 ImagingStudy-subject
.... 17.21 Observation-category
.... 17.22 Observation-code
.... 17.23 Observation-date
.... 17.24 Observation-id
.... 17.25 Observation-performer
.... 17.26 Observation-status
.... 17.27 Observation-subject
.... 17.28 醫學影像報告邏輯模型
.... 17.29 非小細胞癌邏輯模型
.... 17.30 非酒精性脂肪肝邏輯模型
.... 17.31 Condition
.... 17.32 DiagnosticReport Image
.... 17.33 DiagnosticReport LC
.... 17.34 Encounter
.... 17.35 Endpoint
.... 17.36 Image Bundle
.... 17.37 Image Composition
.... 17.38 ImagingStudy
.... 17.39 Media
.... 17.40 NASH DiagnosticReport
.... 17.41 Observation Imaging result
.... 17.42 Observation LC Ancillary studies
.... 17.43 Observation LC Angiolymphatic invasion
.... 17.44 Observation LC Cell type
.... 17.45 Observation LC Gross Finding
.... 17.46 Observation LC Histologic pattern
.... 17.47 Observation LC Histologic type
.... 17.48 Observation LC Lymph nodes
.... 17.49 Observation LC Metastasis
.... 17.50 Observation LC Non-tumorous parenchma
.... 17.51 Observation LC Pathological staging
.... 17.52 Observation LC Perineural invasion
.... 17.53 Observation LC Pleural invasion
.... 17.54 Observation LC Resection margin
.... 17.55 Observation LC Size of invasive focus
.... 17.56 Observation LC Spread Through Air Spaces (STAS)
.... 17.57 Observation LC T category
.... 17.58 Observation LC Total tumor size
.... 17.59 Observation LC Treatment effect
.... 17.60 Observation LC Tumor grading
.... 17.61 Observation LC Tumor necrosis
.... 17.62 Observation NASH Ballooning
.... 17.63 Observation NASH Brunt scoring system
.... 17.64 Observation NASH CRN scoring system
.... 17.65 Observation NASH Fibrosis
.... 17.66 Observation NASH Fibrosis
.... 17.67 Observation NASH Fibrosis stage
.... 17.68 Observation NASH Intralobular degeneration/necrosis
.... 17.69 Observation NASH Knodell score system
.... 17.70 Observation NASH Lobular inflammation
.... 17.71 Observation NASH Metavir fibrosis score
.... 17.72 Observation NASH Necroinflammatory Grading
.... 17.73 Observation NASH Periportal/bridging necrosis
.... 17.74 Observation NASH Portal inflammation
.... 17.75 Observation NASH Sample size
.... 17.76 Observation NASH Steatosis
.... 17.77 Organization
.... 17.78 Patient
.... 17.79 Practitioner
.... 17.80 基於 TW CORE IG 的 Specimen
.... 17.81 Acquisition Modality
.... 17.82 ICD-O-3 Morphology
.... 17.83 ImagingStudy Category Type
.... 17.84 ImagingStudy Identifier Type
.... 17.85 LOINC Radiology
.... 17.86 NASH-Ballooning
.... 17.87 NASH-Fibrosis
.... 17.88 NASH-Fibrosis Staging
.... 17.89 NASH-Fibrosis-Stage
.... 17.90 NASH-Intralobular Degeneration/Necrosis
.... 17.91 NASH-Knodell score system
.... 17.92 NASH-Lobular Inflammation
.... 17.93 NASH-Metavir Fibrosis Score
.... 17.94 NASH-NASH-Periportal/Bridging Necrosis
.... 17.95 NASH-Necroinflammatory Grading
.... 17.96 NASH-Portal-Inflammation
.... 17.97 NASH-Stage
.... 17.98 NASH-Steatosis
.... 17.99 NASH_variables
.... 17.100 NSCLC-Histologic-pattern
.... 17.101 NSCLC-Invasion
.... 17.102 NSCLC-MicroscopicFinding
.... 17.103 NSCLC-Pleural invasion
.... 17.104 NSCLC-pM
.... 17.105 NSCLC-pN
.... 17.106 NSCLC-pT
.... 17.107 NSCLC-pTNM
.... 17.108 NSCLC-WHO GRADE
.... 17.109 臺灣健保署2023年中文版ICD-10-PCS-B-Imaging值集
.... 17.110 臺灣健保署2023年中文版ICD-10-PCS-C-Nuclear Medicine 值集
.... 17.111 臺灣健保署2023年中文版ICD-10-PCS-D-Radiation Therapy值集
.... 17.112 Acquisition Modality
.... 17.113 ICD-O-3 Morphology
.... 17.114 ImagingStudy Identifier Type
.... 17.115 NASH-Ballooning
.... 17.116 NASH-Fibrosis
.... 17.117 NASH-Fibrosis Staging
.... 17.118 NASH-Fibrosis-Stage
.... 17.119 NASH-Intralobular Degeneration/Necrosis
.... 17.120 NASH-Knodell score system
.... 17.121 NASH-Lobular Inflammation
.... 17.122 NASH-Necroinflammatory Grading
.... 17.123 NASH-Periportal/Bridging Necrosis
.... 17.124 NASH-Portal-Inflammation
.... 17.125 NASH-Stage
.... 17.126 NASH-Steatosis
.... 17.127 NASH_variables
.... 17.128 NSCLC-Histologic-pattern
.... 17.129 NSCLC-MicroscopicFinding
.... 17.130 NSCLC-Pleural invasion
.... 17.131 NSCLC-pM
.... 17.132 NSCLC-pN
.... 17.133 NSCLC-pT
.... 17.134 NSCLC-pTNM
.... 17.135 NSCLC-WHO GRADE
.... 17.136 臺灣2023年中文版ICD-10-PCS-B-Imaging
.... 17.137 臺灣2023年中文版ICD-10-PCS-C-NuclearMedicine
.... 17.138 臺灣2023年中文版ICD-10-PCS-D-RadiationTherapy
.... 17.139 Ancillarystudies
.... 17.140 Angiolymphaticinvasion
.... 17.141 Celltype
.... 17.142 DiagnosticReportLC
.... 17.143 GrossFinding
.... 17.144 Histologicpattern
.... 17.145 Histologictype
.... 17.146 ImageBundle
.... 17.147 ImageDiagnosticReport
.... 17.148 ImagingStudyBase
.... 17.149 Lymphnodes
.... 17.150 MediaBase
.... 17.151 Metastasis
.... 17.152 MitwEndpoint
.... 17.153 NASHBallooning
.... 17.154 NASHBruntScoringSystem
.... 17.155 NASHCRNScoringSystem
.... 17.156 NASHDiagnosticReport
.... 17.157 NASHFibrosis
.... 17.158 NASHFibrosisStage
.... 17.159 NASHFibrosisStaging
.... 17.160 NASHGrossFinding
.... 17.161 NASHIntralobularDegenerationNecrosis
.... 17.162 NASHKnodellScoreSystem
.... 17.163 NASHLobularInflammation
.... 17.164 NASHMetavirFibrosisScore
.... 17.165 NASHNecroinflammatoryGrading
.... 17.166 NASHPeriportalBridgingNecrosis
.... 17.167 NASHPortalInflammation
.... 17.168 NASHSteatosis
.... 17.169 Nontumorousparenchyma
.... 17.170 ObservationImagingResult
.... 17.171 Pathologicalstaging
.... 17.172 Perineuralinvasion
.... 17.173 Pleuralinvasion
.... 17.174 Resectionmargin
.... 17.175 Sizeofinvasivefocus
.... 17.176 SpreadThroughAirSpaces
.... 17.177 Tcategory
.... 17.178 Totaltumorsize
.... 17.179 Treatmenteffect
.... 17.180 Tumorgrading
.... 17.181 Tumornecrosis
.... 17.182 TWCoreCondition
.... 17.183 TWCoreEncounter
.... 17.184 TWCoreOrganization
.... 17.185 TWCorePatient
.... 17.186 TWCorePractitioner
.... 17.187 TWCoreSpecimen
.... 17.188 醫療影像及報告